US Stock MarketDetailed Quotes
IMNM Immunome
- 13.540
- -0.680-4.78%
Close Sep 6 16:00 ET
- 13.540
- 0.0000.00%
Post 17:03 ET
813.14MMarket Cap-1795P/E (TTM)
14.380High13.230Low640.71KVolume14.180Open14.220Pre Close8.71MTurnover1.49%Turnover RatioLossP/E (Static)60.05MShares30.95852wk High3.20P/B582.82MFloat Cap6.65052wk Low--Dividend TTM43.04MShs Float63.780Historical High--Div YieldTTM8.09%Amplitude2.090Historical Low13.601Avg Price1Lot Size
Immunome Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -312.79%-23.4M | -146.21%-11.17M | 73.62%-7.57M | -161.24%-17.46M | -13.78%-8.61M | 29.68%-5.67M | 479.12%24.17M | -57.41%-28.69M | 1.79%-6.68M | -82.65%-7.57M |
| Net income from continuing operations | -550.03%-36.12M | -2,932.60%-129.49M | -189.48%-106.81M | -1,089.75%-92.63M | 49.08%-4.35M | 37.73%-5.56M | 63.36%-4.27M | -49.31%-36.9M | 0.84%-7.79M | -10.53%-8.53M |
| Depreciation and amortization | 328.66%673K | 77.70%263K | 15.37%728K | -1.15%257K | 45.61%166K | 29.75%157K | 8.82%148K | -16.42%631K | 120.34%260K | -60.14%114K |
| Other non cash items | --6.31M | --111.95M | --80.8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 320.22%2.87M | -83.44%4.48M | 434.86%12M | -1,447.46%-7.92M | -1,089.02%-5.85M | -122.77%-1.3M | 606.63%27.07M | -19.26%2.24M | -69.54%-512K | -123.00%-492K |
| -Change in prepaid assets | -259.28%-1.6M | 1,055.61%2.47M | -181.72%-4.14M | -3,352.73%-5.7M | -57.23%337K | 110.95%1M | -94.61%214K | 218.45%5.07M | 93.30%-165K | 140.18%788K |
| -Change in payables and accrued expense | 250.36%6.87M | 527.48%3.07M | 100.23%6K | 830.00%1.39M | -110.09%-2.62M | 289.19%1.96M | -478.23%-717K | -136.82%-2.6M | -108.80%-190K | -130.46%-1.25M |
| -Change in other current liabilities | ---42K | 59.68%-25K | 166.81%153K | 235.67%213K | 106.45%2K | --0 | -244.44%-62K | ---229K | ---157K | ---31K |
| -Change in other working capital | 44.55%-2.36M | -103.72%-1.03M | --15.98M | ---3.83M | ---3.57M | ---4.26M | --27.64M | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -312.79%-23.4M | -146.21%-11.17M | 73.62%-7.57M | -161.24%-17.46M | -13.78%-8.61M | 29.68%-5.67M | 479.12%24.17M | -57.41%-28.69M | 1.79%-6.68M | -82.65%-7.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -23,925.88%-81.69M | -35,023.58%-37.23M | -12,191.94%-30.48M | -41,569.44%-30M | -36K | -100.00%-340K | -1,666.67%-106K | -213.92%-248K | -414.29%-72K | 0 |
| Net PPE purchase and sale | -589.41%-2.34M | -1,941.51%-2.16M | -235.08%-831K | -384.72%-349K | ---36K | -100.00%-340K | -1,666.67%-106K | -213.92%-248K | -414.29%-72K | --0 |
| Net intangibles purchase and sale | ---26.72M | ---15.01M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net business purchase and sale | ---- | ---20.06M | --9.28M | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---38.93M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -23,925.88%-81.69M | -35,023.58%-37.23M | -12,191.94%-30.48M | -41,569.44%-30M | ---36K | -100.00%-340K | -1,666.67%-106K | -213.92%-248K | -414.29%-72K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 694K | 645,326.47%219.45M | 363,675.00%116.41M | 55.5M | 60.88M | 0 | 6.25%34K | -99.88%32K | 0 | 0 |
| Net common stock issuance | --0 | 676,376.47%230M | --34K | --0 | --0 | --0 | --34K | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --1.16M | --3.6M | 391,684.38%125.37M | --125.37M | --0 | --0 | --0 | -97.77%32K | --0 | --0 |
| Net other financing activities | ---469K | ---14.16M | ---9M | ---8.87M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --694K | 645,326.47%219.45M | 363,675.00%116.41M | --55.5M | --60.88M | --0 | 6.25%34K | -99.88%32K | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 506.02%269.82M | 383.67%98.78M | -58.60%20.42M | 233.88%90.74M | 10.84%38.52M | 3.59%44.52M | -58.60%20.42M | 23.74%49.33M | -51.76%27.18M | -42.02%34.75M |
| Current changes in cash | -1,637.53%-104.39M | 609.70%171.04M | 371.07%78.36M | 218.99%8.04M | 789.80%52.23M | 27.00%-6.01M | 479.54%24.1M | -405.46%-28.91M | 3.69%-6.76M | -111.13%-7.57M |
| End cash Position | 329.52%165.43M | 506.02%269.82M | 383.67%98.78M | 383.67%98.78M | 233.88%90.74M | 10.84%38.52M | 3.59%44.52M | -58.60%20.42M | -58.60%20.42M | -51.76%27.18M |
| Free cash flow | -773.12%-52.46M | -217.76%-28.34M | 70.98%-8.4M | -163.63%-17.81M | -14.25%-8.65M | 27.00%-6.01M | 477.11%24.07M | -58.09%-28.94M | 0.94%-6.76M | -81.52%-7.57M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg